Home › Forums › Main Forum › Media & News › FDA Grants Priority Reveiw Sofosbuvir/Velpatasvir
http://hepatitiscnewdrugs.blogspot.com.au/2016/01/gileadfda-grants-priority-review-for.html
G3a since ’78 – Dx ’12 – F4 (2xHCC) 24wk Tx – PEG/Riba/Dac 2013 relapsed 24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 – 22/06/17 UND SRV12 – 27/07/17 UND SVR24 – 26/10/17 UND